The Effect of Subcutaneous Treprostinil on Pulmonary Hypertension Associated with Interstitial Lung Disease

被引:0
|
作者
Sadushi-Kolici, Roela [1 ]
Shafran, Inbal [2 ]
Prosch, Helmut [3 ]
Skoro-Sajer, Nika [1 ]
Gerges, Christin [1 ]
Lang, Irene [1 ]
机构
[1] Med Univ Vienna, Cardiol, Internal Med 2, Vienna, Austria
[2] Sheba Med Ctr, Ramat Gan, Israel
[3] Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria
关键词
D O I
10.1183/13993003.congress-2023.PA3487
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study
    Weatherald, Jason
    Nathan, Steven D.
    El-Kersh, Karim
    Argula, Rahul G.
    DuBrock, Hilary M.
    Rischard, Franz P.
    Cassady, Steven J.
    Tarver, James
    Levine, Deborah J.
    Tapson, Victor F.
    Deng, Chunqin
    Shen, Eric
    Das, Manisit
    Waxman, Aaron B.
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (01)
  • [32] The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease
    Corte, Tamera J.
    Gatzoulis, Michael A.
    Parfitt, Lisa
    Harries, Carl
    Wells, Athol U.
    Wort, S. John
    RESPIROLOGY, 2010, 15 (08) : 1226 - 1232
  • [33] Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Response
    Nathan, Steven D.
    Shen, Eric
    Deng, Chunqin
    CHEST, 2024, 165 (05) : e162 - e162
  • [34] Interstitial lung disease and pulmonary hypertension associated with epidermolysis bullosa in an infant
    Doeker, B
    Hussein, A
    Trowitzsch, E
    KLINISCHE PADIATRIE, 1998, 210 (05): : 340 - 344
  • [35] Subcutaneous treprostinil in pediatric pulmonary arterial hypertension.
    Bajolle, F.
    Levy, M.
    Szezepanski, I.
    Bonnet, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [36] Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations
    Mathier, Michael A.
    McDevitt, Susanne
    Saggar, Rajan
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (11): : 1210 - 1217
  • [37] Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
    Vernetta, Alba Torrent
    Amigo, Sandra Rovira
    Serrano, Ignacio Iglesias
    Morillo, Maria
    Messa, Ines de Mir
    Gartner, Silvia
    Brotons, Dimpna Albert
    Galdo, Antonio Moreno
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [38] Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
    Nathan, Steven D.
    Waxman, Aaron
    Rajagopal, Sudarshan
    Case, Amy
    Johri, Shilpa
    DuBrock, Hilary
    De La Zerda, David J.
    Sahay, Sandeep
    King, Christopher
    Melendres-Groves, Lana
    Smith, Peter
    Shen, Eric
    Edwards, Lisa D.
    Nelsen, Andrew
    Tapson, Victor F.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (11): : 1266 - 1274
  • [39] Comparison of Scleroderma Associated Isolated Pulmonary Arterial Hypertension and Pulmonary Hypertension with Concomitant Interstitial Lung Disease
    Hannan, Alexander
    Dweik, Raed
    Highland, Kristin B.
    Heresi, Gustavo
    Tonelli, Adriano
    Messner, William
    Chatterjee, Soumya
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] Pulmonary hypertension secondary to interstitial lung disease
    Shlobin, Oksana A.
    Nathan, Steven D.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 179 - 189